| PF-06424439 |
PF-06424439 |
1469284-78-3 |
| 1H-Benz[e]indolium, 2-[5-(1,3-dihydro-1,1,3-trimethyl-2H-benz[e]indol-2-ylidene)-1,3-pentadien-1-yl]-3-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl]-1,1-dimethyl-, chloride (1:1) |
CY5.5 N-羟基琥珀酰亚胺酯 |
1469277-96-0 |
| (S)-[2’-(2-naphthylmethyl)-[1,1’-binaphthalen]-2-yl]diphenylphosphine |
(S)-[2'-(2-萘基甲基)-[1,1'-联萘]-2-基]二苯基膦 |
1454319-50-6 |
| (S)-[2’-(2-Methoxybenzyl)-[1,1’-binaphthalen]-2-yl]diphenylphosphine |
(S)-[2’-(2-Methoxybenzyl)-[1,1’-binaphthalen]-2-yl]diphenylphosphine |
1454319-48-2 |
| (S)-[2’-(4-Methylbenzyl)-[1,1’-binaphthalen]-2-yl]diphenylphosphine |
(S)-[2'-(4-甲基苄基)-[1,1'-联萘]-2-基]二苯基膦 |
1454319-49-3 |
| (1R,1’R)-1,1’-[(S)-[1,1’-Binaphthalene]-2,2’-diyl]bis(2-propen-1-ol) |
(1R,1'R)-1,1'-[(S)-[1,1'-联萘]-2,2'-二基]二(2-丙烯-1-醇) |
1451057-19-4 |
| BMX-IN-1 |
N-[2-甲基-5-[9-[4-[(甲基磺酰基)氨基]苯基]-2-氧代苯并[H]-1,6-萘啶-1(2H)-基]苯基]-2-丙烯酰胺 |
1431525-23-3 |
| BAY57-1293 mesylate |
BAY57-1293 甲磺酸盐 |
1428333-96-3 |
| CDKI-73 |
CS-2259 |
1421693-22-2 |
| Hexanoic acid, 4-methyl-5-oxo-, sodium salt (1:1) |
ERG240 |
1415683-79-2 |
| (1R,1’’R)-3,3’’-[[(1S,2S)-Cyclohexane-1,2-diylbis(azanediyl)]bis(methylene)]bis(2’-benzyl-[1,1’-binaphthalen]-2-ol) |
(1R,1''R)-3,3''-[[(1S,2S)-环己烷-1,2-二基二(氮二基)]二(亚甲基)]二(2'-苄基-[1,1'-联萘]-2-醇) |
1403589-08-1 |
| GSK2879552 |
GSK2879552 |
1401966-69-5 |
| (2S)-2-(3-Aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3(2H)-carboxamide Hydrochloride |
(2S)-2-(3-Aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3(2H)-carboxamide Hydrochloride |
1385020-40-5 |
| SR9009 |
SR9009 |
1379686-30-2 |
| Lambrolizumab |
派姆单抗 |
1374853-91-4 |
| 2,9-Diazaspiro[5.5]undecan-1-one, 2-(1H-indol-3-ylMethyl)-9-(4-Methoxy-2-pyriMidinyl)- |
2,9-Diazaspiro[5.5]undecan-1-one, 2-(1H-indol-3-ylMethyl)-9-(4-Methoxy-2-pyriMidinyl)- |
1373765-19-5 |
| ML-228 |
KC7F2 |
1357171-62-0 |
| 1353546-86-7 |
IBI353 |
1353546-86-7 |
| UNC569 |
CS-2399 |
1350547-65-7 |
| ML 154 |
化合物ML 154 |
1345964-89-7 |
